The extraordinary commitment of patients and clinicians has put RNSH at the forefront of renal research, generating evidence that is helping to change outcomes for people with kidney disease around the world.
Rebecca Stevenson
Rebecca says many trials are testing different ways of delivering treatments and aim is to give patients more choices and help new medicines reach people in low-and middle-income countries, where kidney disease is common and treatment options are limited. “Oral medications are obviously much easier to transport and deliver to people all around the world rather than injections and having to keep things in the fridge,” she explains. The extraordinary commitment of patients and clinicians has put RNSH at the forefront of renal research, generating evidence that is helping to change outcomes for people with kidney disease around the world. The trials also provide hope to patients.
“I really love the patient contact and the opportunity to offer treatments to patients that are not otherwise available,” says Rebecca.
“There are cases where I’ve seen our patients try new treatments through clinical trials that have since gone on to become approved for public use and have delivered substantial benefits. Seeing those positive outcomes has been incredibly rewarding.”
19
Made with FlippingBook - professional solution for displaying marketing and sales documents online